Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences CAMBRIDGE, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013 at 2:50 p.m. ET at the Boston Marriott Copley Place and at the Barclays Global Healthcare Conference on March 13, 2013 at 3:15 p.m. ET at the Loews Miami Hotel. The live and archived webcasts of the company presentations can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com. CONTACT: Idenix Pharmaceuticals Contacts: Kelly Barry (617) 995-9033 (media) Teri Dahlman (617) 995-9807 (investors)
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Press spacebar to pause and continue. Press esc to stop.